Home

Jenburkt Pharmaceuticals Ltd EPS

Image

Jenburkt Pharmaceuticals Ltd

NSE: JENBURKTPHARMA

EPS

₹ 71.16

Last updated on: Feb 21, 2025

Key Highlights

  • The Earning per Share of Jenburkt Pharmaceuticals Ltd is ₹ 71.16 as of 21 Feb 25 .
  • The earning per share of Jenburkt Pharmaceuticals Ltd changed from ₹ 12.17 to ₹ 14.75 over 7 quarters. This represents a CAGR of 11.61% .

Historical Earning per Share of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Jenburkt Pharmaceuticals Ltd

Market Cap

443 Cr

EPS

71.2

P/E Ratio (TTM)

14.1

P/B Ratio (TTM)

2.8

Day’s High

1030.0

Day’s Low

996.1

DTE

0.0

ROE

19.2

52 Week High

1375.0

52 Week Low

660.05

ROCE

25.3

Market Price of Jenburkt Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Jenburkt Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 20251004.3
20 Feb 20251023.25
19 Feb 20251019.4
18 Feb 2025966.7
17 Feb 20251017
14 Feb 20251029.05
13 Feb 20251095.25
12 Feb 20251069.85
11 Feb 20251056.8
10 Feb 20251089.45

SWOT Analysis Of Jenburkt Pharmaceuticals Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Jenburkt Pharmaceuticals Ltd

Asset Value vs Market Value of Jenburkt Pharmaceuticals Ltd

Market Value

443

Asset Value

Value addition

3.0 X

112

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Jenburkt Pharmaceuticals Ltd443.23
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

Historical Market Cap of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Jenburkt Pharmaceuticals Ltd News Hub

Jenburkt Pharmaceuticals to announce Quarterly Result

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November

Read more

29 Oct 24

Jenburkt Pharmaceuticals standalone net profit rises 31.15% in the September 2024 quarter

Net profit of Jenburkt Pharmaceuticals rose 31.15% to Rs 9.60 crore in the quarter ended September 2

Read more

05 Nov 24

Jenburkt Pharmaceuticals to table results

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 January

Read more

21 Jan 25

Jenburkt Pharmaceuticals standalone net profit rises 20.56% in the December 2024 quarter

Net profit of Jenburkt Pharmaceuticals rose 20.56% to Rs 6.51 crore in the quarter ended December 20

Read more

29 Jan 25

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Jenburkt Pharmaceuticals Ltd

What is the EPS of Jenburkt Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Jenburkt Pharmaceuticals Ltd is 71.16. An EPS is the amount of net income attributed to each share of a common stock.

How is Jenburkt Pharmaceuticals Ltd EPS calculated?

The EPS of Jenburkt Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Jenburkt Pharmaceuticals Ltd report its EPS?

Jenburkt Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Jenburkt Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Jenburkt Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Jenburkt Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Jenburkt Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions